Right ventricular outflow tract obstruction risk factors
|
Right ventricular outflow tract obstruction Microchapters |
|
Classification |
|---|
|
Differentiating Right ventricular outflow tract obstruction from other Diseases |
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Right ventricular outflow tract obstruction risk factors On the Web |
|
FDA on Right ventricular outflow tract obstruction risk factors |
|
CDC on Right ventricular outflow tract obstruction risk factors |
|
Right ventricular outflow tract obstruction risk factors in the news |
|
Blogs on Right ventricular outflow tract obstruction risk factors |
|
Directions to Hospitals Treating Right ventricular outflow tract obstruction risk factors |
|
Risk calculators and risk factors for Right ventricular outflow tract obstruction risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including right ventricular outflow tract obstruction. [1]